drug
calcium acetate
Marketedupdated 3mo agoby Nostrum Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying calcium acetate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 20, 2027
335 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Feb 23, 2030formulationUS 85919383.5y
- Jul 20, 2027method-of-use (U-1469)US 8592480335d
- Jul 20, 2027method-of-use (U-1469)US 9089528335d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that